Veru Inc.
VERU · NASDAQ
Bulios Fair Price
$3.03
21.2% upside
Trenutna cena
$2.5
Po podatkih Bulios Fair Price je delnica VERU trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Veru Inc. (VERU) is an American pharmaceutical company focused on research, development, and commercialization of therapeutic products in the fields of urology and oncology. The company specializes in the treatment of oncological diseases, including prostate, breast, and other malignancies. Veru is also involved in the treatment of sexually transmitted infections and other urological indications. The company is dedicated to innovative therapeutic approaches and researching new drugs to improve the quality of life for patients and provide them with new treatment options. Veru Inc. has a strong foundation in medical research and development and collaborates with renowned experts in the fields of oncology and urology. Investing in Veru Inc. (VERU) shares may represent an attractive choice for investors who follow the pharmaceutical sector and seek a company with potential in innovative treatments for oncological and urological diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Mitchell S. Steiner
Employees
20
Headquarters
Miami
Prihajajoči dogodki
Earnings
Upcoming earnings report
Earnings
Upcoming earnings report